Mohammad Jahanzeb, MD, FACP, shares his thoughts on the continuation of pemetrexed maintenance after treatment of the patient with carboplatin, pemetrexed and pembrolizumab at Annual Meeting 2018.
Advertisement
Advertisement
[the_ad id="32629"]